1. Home
  2. LQDA vs ALK Comparison

LQDA vs ALK Comparison

Compare LQDA & ALK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

HOLD

Current Price

$78.03

Market Cap

5.5B

Sector

Health Care

ML Signal

HOLD

Logo Alaska Air Group Inc.

ALK

Alaska Air Group Inc.

HOLD

Current Price

$53.24

Market Cap

5.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDA
ALK
Founded
2004
1932
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.1B
IPO Year
2020
2003

Fundamental Metrics

Financial Performance
Metric
LQDA
ALK
Price
$78.03
$53.24
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
12
Target Price
$41.00
$62.92
AVG Volume (30 Days)
2.4M
3.2M
Earning Date
05-08-2026
04-20-2026
Dividend Yield
N/A
N/A
EPS Growth
51.81
N/A
EPS
0.52
N/A
Revenue
$158,320,000.00
$10,426,000,000.00
Revenue This Year
$278.87
$11.19
Revenue Next Year
$57.13
$5.11
P/E Ratio
$147.92
N/A
Revenue Growth
1031.18
8.09
52 Week Low
$11.85
$33.03
52 Week High
$78.25
$65.35

Technical Indicators

Market Signals
Indicator
LQDA
ALK
Relative Strength Index (RSI) 75.44 70.09
Support Level $31.23 $36.64
Resistance Level N/A $56.43
Average True Range (ATR) 4.14 2.41
MACD 0.40 0.60
Stochastic Oscillator 91.55 90.94

Price Performance

Historical Comparison
LQDA
ALK

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

About ALK Alaska Air Group Inc.

Alaska Air Group Inc operates two airlines, Alaska and Horizon, in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements. The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary, and Mileage Plan passenger revenue.

Share on Social Networks: